FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T Cell-induced severe or life-threatening cytokine release syndrome Oncologist, 23 (Aug(8)) (2018), pp. 943-947 CrossrefView in ScopusGoogle Scholar Lee et al., 2014 D.W. Lee, R. Gardner, D.L. Porter, et al...
Not FDA-labeled for IV administration in the management of SSc-ILD or for sub-Q administration in the management of CRS.Administer tocilizumab and tocilizumab-bavi by IV infusion for the management of COVID-19. Not FDA-labeled for sub-Q administration in the management of COVID-19.IV...
Approval History Drug history at FDA Loading... User Reviews & Ratings 6.9 / 10 55 Reviews Related News FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra Images Actemra (tocilizumab) 80 mg/4 mL injection View larger images Drugs...
Moreover, tocilizumab is additionally FDA approved to manage CRS in patients who receive CAR T-cell therapy [17], [18], with which our center has experience. Tocilizumab was approved in China in March 2020 for the treatment of patients with COVID-19 and severe pulmonary disease associated ...
The following adverse reactions have been identified during post-approval use of ACTEMRA. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. ...
Advise the patient to read the FDA-approved patient labeling (Medication Guide). Serious Infections Inform patients that TOFIDENCE may lower their resistance to infections [see WARNINGS AND PRECAUTIONS]. Instruct the patient of the importance of contacting their doctor immediately when symptoms suggesting...
You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345. RELATED Treating Opioid Use Disorder With Medications Choosing the Right...
FDA approval history Drug class: interleukin inhibitors Breastfeeding En español Patient resources Tofidence drug information Tofidence (Tocilizumab Intravenous, Subcutaneous) (Advanced Reading) Other brands Actemra, Tyenne Professional resources Tofidence prescribing information Tocilizumab (AHFS Monograph) Ot...
Approval History Drug history at FDA Loading... User Reviews & Ratings 6.9 / 10 55 Reviews Related News FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra Images Actemra (tocilizumab) 80 mg/4 mL injection View larger images Drugs...
Approval History Drug history at FDA Loading... User Reviews & Ratings 6.9 / 10 55 Reviews Related News FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra Images Actemra (tocilizumab) 80 mg/4 mL injection View larger images Drugs...